Introduction: A recent study indicates that the serotonin transporter function varies with the duration of monthly sunshine. This finding may suggest that the efficacy of serotonin selective reuptake inhibitors (SSRIs) is associated with the duration of monthly sunshine, but information on this possible association is lacking.
Methods: Ninety-one Japanese subjects with depression completed a 6-week treatment with paroxetine. Clinical evaluation was performed using the Montgomery and Asberg Depression Rating Scale (MADRS) before treatment and after 1, 2, 4 and 6 weeks of treatment. Data on the duration of monthly sunshine were obtained from the meteorological agency website. We divided the patients into four groups: nonresponders (NRs), later responders (LRs), early responders (ERs) and ultra-early responders (UERs).
Results: The responses to paroxetine treatment of the group that began treatment in fall and winter and of the group that began treatment in spring and summer did not differ significantly. The effect of the duration of monthly sunshine on paroxetine response time did not differ significantly among the four groups, whereas the change in the duration of monthly sunshine had a significant effect on paroxetine response time.
Limitations: Our sample of patients with MDD was small and only included the Hirosaki area.
Conclusion: The change in the duration of monthly sunshine is associated with paroxetine response time.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jad.2011.11.012 | DOI Listing |
SAGE Open Nurs
January 2025
Nursing Department, College of Health Sciences, Arsi University, Asella, Oromia Regional State, Ethiopia.
Introduction: Globally, chronic kidney disease (CKD) has emerged as one of the leading causes of mortality and it is one of a small number of noncommunicable diseases that have shown an increase in associated deaths over the past two decades. Chronic kidney disease affects approximately 50% of patients with type 2 diabetic mellitus (DM).
Objective: To determine CKD preventive attitude, practices, and associated factors among type 2 DM (T2DM) patients attending follow-up in a diabetic clinic at Asella Referral and Teaching Hospital.
BMC Public Health
January 2025
School of Public Health, General Hospital of Ningxia Medical University, Ningxia Medical University, Yinchuan, Ningxia, 750004, People's Republic of China.
Background: Mental health issues, particularly anxiety and depression, are increasingly prevalent among the occupational population. Environmental factors, such as dust exposure, may contribute to the worsening of these symptoms. While previous studies have examined the association between dust exposure and mental health, the moderating effect of sleep duration on this link in occupational settings remains under-explored.
View Article and Find Full Text PDFLaryngoscope
January 2025
Otolaryngology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Objectives: To analyze the prognostic value of markers available at the onset of idiopathic facial palsy. To define the evolution of the episode by tracing changes in facial function over time.
Methods: This is an observational prospective study on patients with facial palsy consulting in the first 24 hs.
BMJ Open Qual
January 2025
Professor Department of Obstetrics and Gynaecology, Lady Hardinge Medical College, New Delhi, India.
Background: Allowing a birth companion is the basic right of a mother and is identified as an important component of respectful maternity care. The implementation of this intervention has been a challenge in heavy-load public health facilities in India.
Local Problem: Despite the proven benefits of the presence of birth companions on maternal-fetal outcomes, there was no policy of allowing birth companions in our hospital.
PLoS One
January 2025
French National Reference Center for Primary Immunodeficiencies (CEREDIH) and Pediatric Immunology, Hematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.
Background: Subcutaneous immunoglobulin (SCIg) replacement therapy is indicated for patients with hypogammaglobulinemia caused by primary (PID) and secondary immunodeficiencies (SID).
Objective: To compare healthcare resource utilization (HCRU) and related direct medical costs of patients in France treated with weekly conventional SCIg (cSCIg) vs monthly hyaluronidase-facilitated SCIg (fSCIg).
Methods: This retrospective study of Ig-naïve patients with PID or SID newly receiving a SCIg between 2016 and 2018, extracted from the French National Healthcare reimbursement database (SNDS), analyzed the SCIg-related HCRU and reimbursed costs generated from in-hospital (hospitalizations and SCIg doses) or at-home (nurse visits [NV] and pump provider visits [PPV], drug doses) SCIg administration.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!